February 27, 2020 / 3:43 PM / a month ago

BRIEF-Boehringer Ingelheim Enters Discovery Stage Collaboration With Trutino Biosciences

Feb 27 (Reuters) - Boehringer Ingelheim

* BOEHRINGER INGELHEIM ENTERS DISCOVERY STAGE COLLABORATION WITH TRUTINO BIOSCIENCES TO GROW ITS CANCER IMMUNOLOGY PORTFOLIO WITH NOVEL CYTOKINE PLATFORM

* BOEHRINGER INGELHEIM - CO GAINS ACCESS TO TRUTINO’S ODC PLATFORM TECHNOLOGY FOR GENERATION & DEVELOPMENT OF UP TO 3 NEW ODC CANDIDATES Source text for Eikon: Further company coverage: [ ]

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below